Form 8-K - Current report:
SEC Accession No. 0000950123-11-026581
Filing Date
2011-03-18
Accepted
2011-03-18 06:02:16
Documents
3
Period of Report
2011-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y04669e8vk.htm 8-K 12738
2 EX-1.1 y04669exv1w1.htm EX-1.1 132735
3 EX-99.1 y04669exv99w1.htm EX-99.1 6311
  Complete submission text file 0000950123-11-026581.txt   153174
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 11696709
SIC: 2836 Biological Products, (No Diagnostic Substances)